Biogen Inc. (BIIB)
NASDAQ: BIIB · Real-Time Price · USD
218.50
-3.00 (-1.35%)
At close: Aug 28, 2026, 4:00 PM EDT
218.19
-0.31 (-0.14%)
After-hours: Aug 28, 2026, 7:30 PM EDT

Biogen Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,2853,0092,3751,0503,4192,261
Short-Term Investments
-807.2--1,4741,541
Cash & Short-Term Investments
1,2853,8162,3751,0504,8933,803
Cash Growth
-53.42%60.66%126.21%-78.54%28.67%45.68%
Accounts Receivable
2,3981,8671,8692,1002,1361,962
Other Receivables
---430798.8-
Receivables
2,3981,8671,8692,5302,9351,962
Inventory
2,3842,1682,4612,5271,3441,352
Prepaid Expenses
648.9693.6307.2---
Other Current Assets
589.1429.7445.3752618.8740.8
Total Current Assets
7,3068,9747,4576,8599,7917,857
Property, Plant & Equipment
3,2403,3213,5383,7303,7033,792
Long-Term Investments
594.2954.5423.8625.81,7762,826
Goodwill
6,9916,4916,4796,2195,7495,761
Other Intangible Assets
13,5169,1799,6918,3631,8502,221
Long-Term Deferred Tax Assets
202.1292.5324.2928.61,2261,415
Other Long-Term Assets
207.6198136.7119.2459.35.5
Total Assets
32,08729,44028,04926,84524,55423,877

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
403.9432424.2403.3491.5589.2
Accrued Expenses
1,7091,6791,5041,4531,4971,382
Current Portion of Long-Term Debt
800-1,749150-999.1
Current Portion of Leases
-80.486.490.397.289.1
Current Income Taxes Payable
86.9114.8548.3257.4259.9174.7
Other Current Liabilities
9171,0441,2181,080927.61,064
Total Current Liabilities
3,9173,3495,5293,4343,2734,298
Long-Term Debt
7,2906,2874,5476,7886,2816,274
Long-Term Leases
264.8290.4334.5400333330.4
Long-Term Deferred Tax Liabilities
945.5507.6190.5641.8334.7694.5
Other Long-Term Liabilities
820.9748.5732.3781.1944.21,321
Total Liabilities
13,23911,18311,33312,04511,16612,918

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
0.10.10.10.10.10.1
Additional Paid-In Capital
983863.1569.4302.573.368.2
Retained Earnings
20,97020,55319,26017,62816,46713,912
Treasury Stock
-2,977-2,977-2,977-2,977-2,977-2,977
Comprehensive Income & Other
-127.7-182-136.2-153.7-164.9-106.7
Total Common Equity
18,84818,25716,71614,79913,39810,896
Minority Interest
-----9.563.5
Shareholders' Equity
18,84818,25716,71614,79913,38810,960
Total Liabilities & Equity
32,08729,44028,04926,84524,55423,877

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
8,3556,6586,7177,4296,7117,693
Net Cash (Debt)
-7,070-2,410-4,342-6,379-1,113-2,998
Net Cash Growth
------
Net Cash Per Share
-47.75-16.38-29.76-43.81-7.62-20.04
Filing Date Shares Outstanding
147.75146.76146.37145.36144.49146.96
Total Common Shares Outstanding
147.7146.8145.8144.9144.1147
Working Capital
3,3895,6251,9283,4256,5183,558
Book Value Per Share
127.61124.37114.65102.1492.9874.12
Tangible Book Value
-1,6592,587545.9217.25,7992,914
Tangible Book Value Per Share
-11.2317.623.741.5040.2419.82
Land
-216.7202.4202.4202.4207.5
Buildings
-2,1401,9641,6011,5931,700
Machinery
-2,2302,1691,7651,6731,653
Construction In Progress
-163.1308.4975.4888.8770.3
Leasehold Improvements
-143.5137.8135.7107.7121
SEC Filings: 10-K · 10-Q